Criblage fonctionnel et ciblage du cancer : P. Martineau

Liste des Publications

Quénet F, Carrère S, Sgarbura O [Contribution of intraperitoneal chemotherapy in the treatment of colorectal peritoneal carcinoma. HIPEC, PIPAC, state of the art and future directions]. Bull Cancer. 2024-02-07. doi:10.1016/j.bulcan.2023.10.006

Trecourt A, Bakrin N, Glehen O, Gertych W, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Genestie C, Dartigues P, Leroux A, Odin C, Khellaf L, Svrcek M, Thierry S, Augros M, Omar A, Devouassoux-Shisheboran M, Kepenekian V Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study. Ann Surg Oncol. 2024-02-10. doi:10.1245/s10434-023-14850-0

Trecourt A, Bakrin N, Glehen O, Gertych W, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Genestie C, Dartigues P, Leroux A, Odin C, Khellaf L, Svrcek M, Thierry S, Augros M, Omar A, Devouassoux-Shisheboran M, Kepenekian V ASO Visual Abstract: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study. Ann Surg Oncol. 2024-02-09. doi:10.1245/s10434-024-14925-6

Desroys du Roure P, Lajoie L, Mallavialle A, Alcaraz L, Mansouri H, Fenou L, Garambois V, Rubio L, David T, Coenon L, Boissière-Michot F, Chateau M-C, Ngo G, Jarlier M, Villalba M, Martineau P, Laurent-Matha V, Roger P, Guiu S, Chardès T, Gros L, Liaudet-Coopman E A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. J Immunother Cancer. 2024;12(1):e007135. doi:10.1136/jitc-2023-007135

Cusumano C, Deshayes E, Guiu B, De Meeus G, Carrère S, Bouillin A, Ilonca D, Éberlé M, Guillemard S, Fersing C, Sgarbura O, Quénet F Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?. Ann Transl Med. 2023;11(5):202. doi:10.21037/atm-22-3665

Cashin P, Esquivel J, Larsen S, Liauw W, Alzahrani N, Morris D, Kepenekian V, Sourrouille I, Tuech J-J, Ceribelli C, Doussot B, Sgarbura O, Glehen O, Fisher O Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study. EClinicalMedicine. 2023;55. doi:10.1016/j.eclinm.2022.101746

Noverraz F, Robin B, Passemard S, Fauvel B, Presumey J, Rigal E, Cookson A, Chopineau J, Martineau P, Villalba M, Jorgensen C, Aubert-Pouëssel A, Morille M, Gerber-Lemaire S Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 antibody. Int J Pharm. 2023;630. doi:10.1016/j.ijpharm.2022.122463

Cassese G, Troisi R, Khayat S, Benoudifa B, Guiu B, Panaro F Liver Venous Deprivation Versus Portal Vein Embolization Before Major Hepatectomy for Colorectal Liver Metastases: A Retrospective Comparison of Short- and Medium-Term Outcomes. J Gastrointest Surg. 2023;27(2):296-305. doi:10.1007/s11605-022-05551-2

Mangeat T, Gracia M, Pichard A, Poty S, Martineau P, Robert B, Deshayes E Fc-engineered monoclonal antibodies to reduce off-target liver uptake. EJNMMI Res. 2023;13(1):81. doi:10.1186/s13550-023-01030-0

David T, Mallavialle A, Faget J, Alcaraz L, Lapierre M, du Roure P, Laurent-Matha V, Mansouri H, Jarlier M, Martineau P, Roger P, Guiu S, Chardès T, Liaudet-Coopman E Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancer. Br J Pharmacol. 2023-11-29. doi:10.1111/bph.16291

Tassou A, Thouaye M, Gilabert D, Jouvenel A, Leyris J-P, Sonrier C, Diouloufet L, Mechaly I, Mallié S, Bertin J, Chentouf M, Neiveyans M, Pugnière M, Martineau P, Robert B, Capdevila X, Valmier J, Rivat C Activation of neuronal FLT3 promotes exaggerated sensorial and emotional pain-related behaviors facilitating the transition from acute to chronic pain. Prog Neurobiol. 2023;222. doi:10.1016/j.pneurobio.2023.102405

Gouyon J, Clavié M, Raquel G-C, Ngo G, Dumy P, Etienne P, Martineau P, Pugnière M, Ahmad M, Subra G, Perrin C, Ladner Y A bioinspired approach for the modulation of electroosmotic flow and protein-surface interactions in capillary electrophoresis using silylated amino-amides blocks and covalent grafting. Electrophoresis. 2023-12-31. doi:10.1002/elps.202300168

Antunes A, Alvarez-Vallina L, Bertoglio F, Bouquin N, Cornen S, Duffieux F, Ferré P, Gillet R, Jorgensen C, Leick M, Maillère B, Negre H, Pelegrin M, Poirier N, Reusch D, Robert B, Serre G, Vicari A, Villalba M, Volpers C, Vuddamalay G, Watier H, Wurch T, Zabeau L, Zielonka S, Zhang B, Beck A, Martineau P 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies. MAbs. 2023;15(1):2211692. doi:10.1080/19420862.2023.2211692

Genest M, Comunale F, Planchon D, Govindin P, Noly D, Vacher S, Bièche I, Robert B, Malhotra H, Schoenit A, Tashireva L, Casas J, Gauthier-Rouvière C, Bodin S Upregulated flotillins and sphingosine kinase 2 derail AXL vesicular traffic to promote epithelial-mesenchymal transition. J Cell Sci. 2022;135(7):jcs259178. doi:10.1242/jcs.259178

Giguelay A, Turtoi E, Khelaf L, Tosato G, Dadi I, Chastel T, Poul M-A, Pratlong M, Nicolescu S, Severac D, Adenis A, Sgarbura O, Carrère S, Rouanet P, Ychou M, Pourquier D, Colombo P-E, Turtoi A, Colinge J The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases. Theranostics. 2022;12(17):7624-7639. doi:10.7150/thno.72853

Khellaf L, Quénet F, Jarlier M, Gil H, Pissas M-H, Carrère S, Samalin E, Mazard T, Ychou M, Sgarbura O, Bibeau F The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases. Surgery. 2022;172(5):1434-1441. doi:10.1016/j.surg.2022.06.032

Denis V, Cassagnard N, Del Rio M, Cornillot E, Bec N, Larroque C, Jeanson L, Jarlier M, Robert B, Gongora C, Martineau P, Dariavach P Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells. PLoS One. 2022;17(9):e0274390. doi:10.1371/journal.pone.0274390

Carbasse C, Leenhardt F, Jacot W, Perrier C, Viala M Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort. Br J Clin Pharmacol. 2022;88(7):3370-3377. doi:10.1111/bcp.15285

Lecointre C, Fourgous E, Montarras I, Kerneur C, Simon V, Boublik Y, Robert B, Martineau P, Roche S Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer. Cancers (Basel). 2022;14(12):2981. doi:10.3390/cancers14122981

Cassese G, Troisi R, Khayat S, Tomassini F, Panaro F, Guiu B Liver venous deprivation versus associating liver partition and portal vein ligation for staged hepatectomy for colo-rectal liver metastases: a comparison of early and late kinetic growth rates, and perioperative and oncological outcomes. Surg Oncol. 2022;43. doi:10.1016/j.suronc.2022.101812

Ferey J, Larroque M, Schmitz-Afonso I, Le Maître J, Sgarbura O, Bouyssiere B, Enjalbal C, Mounicou S, Afonso C Imaging Matrix-Assisted Laser Desorption/Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry of oxaliplatin derivatives in human tissue sections. Talanta. 2022;237. doi:10.1016/j.talanta.2021.122915

Taibi A, Sgarbura O, Hübner M, Bardet S, Alyami M, Bakrin N, Durand Fontanier S, Eveno C, Pache B, Pocard M, Teixeira Farinha H, Thibaudeau E, Dumont F, Glehen O Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study. Ann Surg Oncol. 2022;29(8):5243-5251. doi:10.1245/s10434-022-11577-2

Delhorme J-B, Villeneuve L, Bouché O, Averous G, Dohan A, Gornet J-M, Bibeau F, Dartigues P, Eveno C, Fontaine J, Kepenekian V, Pocard M, Rousset P, Mariani P, Glehen O Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Dig Liver Dis. 2022;54(1):30-39. doi:10.1016/j.dld.2021.10.005

Rubira L, Leenhardt F, Perrier C, Pinguet F [Securing the patient's care path receiving oral anticancer therapy: Experimentation around a pharmaceutical hospital-to-community liaison]. Ann Pharm Fr. 2021-02-04. doi:10.1016/j.pharma.2021.01.009

Arnaudguilhem C, Larroque M, Sgarbura O, Michau D, Carrère S, Mounicou S Toward a comprehensive study for multielemental quantitative LA-ICP MS bioimaging in soft tissues. Talanta. 2021;222. doi:10.1016/j.talanta.2020.121537

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés